Literature DB >> 30642721

Dual rapid test for HIV and syphilis: A laboratory evaluation of the diagnostic accuracy of the Standard Q HIV/Syphilis Combo Test.

Claire C Bristow1, Silver Keith Vargas Rivera2, Lourdes B Ramos Cordova2, Luz Jazmín Qquellon Palacios2, Kelika A Konda3, Jeffrey D Klausner4.   

Abstract

We evaluated the Standard Q HIV/Syphilis Combo Test (SD Biosensor, South Korea), a dual rapid test using stored sera (N = 400) in a laboratory setting in Lima, Peru. The sensitivity and specificity for HIV antibody detection was 100.0% (95% CI: 98.2-100.0%) and 99.5% (95% CI: 97.2-100.0%), respectively. For treponemal antibody detection the sensitivity and specificity was 97.5% (95%CI:94.3-99.2%) and 100.0% (95%CI:98.2-100.0%), respectively.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diagnosis; Dual test; HIV; Rapid test; Treponema pallidum

Mesh：

Substances：

Year:  2018        PMID： 30642721      PMCID： PMC6462422          DOI： 10.1016/j.diagmicrobio.2018.11.018

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  9 in total

Review 1.  Prevalence of sexually transmitted co-infections in people living with HIV/AIDS: systematic review with implications for using HIV treatments for prevention.

Authors:  Seth C Kalichman; Jennifer Pellowski; Christina Turner
Journal:  Sex Transm Infect       Date:  2011-02-17       Impact factor: 3.519

2.  Asymptomatic sexually transmitted infections in HIV-infected men who have sex with men: prevalence, incidence, predictors, and screening strategies.

Authors:  Gunter Rieg; Roger J Lewis; Loren G Miller; Mallory D Witt; Mario Guerrero; Eric S Daar
Journal:  AIDS Patient Care STDS       Date:  2008-12       Impact factor: 5.078

Review 3.  Point-of-care testing for sexually transmitted infections: recent advances and implications for disease control.

Authors:  Joseph D Tucker; Cedric H Bien; Rosanna W Peeling
Journal:  Curr Opin Infect Dis       Date:  2013-02       Impact factor: 4.915

4.  An Update on the Global Epidemiology of Syphilis.

Authors:  Noah Kojima; Jeffrey D Klausner
Journal:  Curr Epidemiol Rep       Date:  2018-02-19

5.  The PICASSO Cohort: baseline characteristics of a cohort of men who have sex with men and male-to-female transgender women at high risk for syphilis infection in Lima, Peru.

Authors:  Noah Kojima; Hayoung Park; Kelika A Konda; Dvora L Joseph Davey; Claire C Bristow; Brandon Brown; Segundo R Leon; Silver K Vargas; Gino M Calvo; Carlos F Caceres; Jeffrey D Klausner
Journal:  BMC Infect Dis       Date:  2017-04-11       Impact factor: 3.090

Review 6.  A systematic review and meta-analysis of studies evaluating the performance and operational characteristics of dual point-of-care tests for HIV and syphilis.

Authors:  Harriet D Gliddon; Rosanna W Peeling; Mary L Kamb; Igor Toskin; Teodora E Wi; Melanie M Taylor
Journal:  Sex Transm Infect       Date:  2017-07-26       Impact factor: 3.519

Review 7.  Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting.

Authors:  Lori Newman; Jane Rowley; Stephen Vander Hoorn; Nalinka Saman Wijesooriya; Magnus Unemo; Nicola Low; Gretchen Stevens; Sami Gottlieb; James Kiarie; Marleen Temmerman
Journal:  PLoS One       Date:  2015-12-08       Impact factor: 3.240

Review 8.  Syphilis Trends among Men Who Have Sex with Men in the United States and Western Europe: A Systematic Review of Trend Studies Published between 2004 and 2015.

Authors:  Winston E Abara; Kristen L Hess; Robyn Neblett Fanfair; Kyle T Bernstein; Gabriela Paz-Bailey
Journal:  PLoS One       Date:  2016-07-22       Impact factor: 3.240

9.  Syphilis incidence among men who have sex with men in China: results from a meta-analysis.

Authors:  Guohong Chen; Ya Cao; Yuan Yao; Ming Li; Weiming Tang; Jianjun Li; Giridhara R Babu; Yue Jia; Xiping Huan; Genxing Xu; Haitao Yang; Gengfeng Fu; Lei Li
Journal:  Int J STD AIDS       Date:  2016-07-10       Impact factor: 1.359
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.